Tirzepatide, the recently approved medication, is generating considerable buzz within the medical community. It functions differently from existing diabetes therapies , targeting multiple receptors involved in blood regulation and appetite . Initial research have demonstrated significant efficacy in reducing blood glucose in individuals with adult-